|
|
|
Keahlian dibuka kepada
semua : Malaysia, Brunei, Singapura, Thailand,
Indonesia dan lain-lain negara |
|
Ingin Buat Belian Tapi...??? |
|
Tiada Internet Banking & Fax |
|
|
Membeli...Cara Mudah |
|
Guna-Telefon sahaja !!! |
|
|
Buat order-Cal:
03-3213 8046 |
|
Dapatkan Kod bayaran anda |
|
|
|
|
|
|
HOT-LINE:03-3213
8046/6563-Fax (8.00AM~5.30PM) SMS:
desakutanya<jarak>tulis
pertanyaan-hantar ke 32781 |
|
|
|
|
Peluang Berniaga ??? |
|
|
|
|

|
|
|
|
-
45 % hingga 55% kandungan
-
Lauric Asid
-
terdapat dalam
-
Minyak Kelapa Dara .
-
Hebat....!!!
|
|
Kehebatan Minyak Kelapa Dara Bio-Asli (Virgin Coconut Oil
) |
|
Tahukah anda ,
pokok kelapa yang mempunyai batang kuat dan mampu tumbuh
tegak berdiri setinggi 100 kaki tanpa ranting yang hanya
bergantung kepada akar rerambut untuk menahan beban yang
berat dan tiupan angin kencang, sebenarnya mempunyai khasiat
semulajadi yang tersembunyi , segagah pohonnya yang tahan
lasak. Kebanyakan pokok kelapa hidup secara " Nactural
Farming " tanpa menggunakan baja kimia, masih mampu
mengeluarkan buah yang banyak. Pokok ini juga terkenal
dengan jolokkan makin tua makin menjadi ,seperti kata
pepatah " makin tua makin pekat dan banyak santannya'. |
|
Saiz=35 ml
Kod=VCO31
Nama=Minyak Power 31
Kegunaan: Untuk suami
H. bukan Ahli: Rm35.00
H.Ahli : xxx + komisyen
|
|
|
|
Apakah
kandungan minyak kelapa dara? |
|
Sekitar awal
1930an kajian saintifik telah dilakukan oleh saintis Eropah dan
Amerika , hasil kajian tersebut mendapati minyak kelapa dara
mempunyi kandungan lemak "saturated, polyunsatured dan
monounsaturated " yang mana ianya mengandunggi " Fatty acid
C6,C8,C10,C12,C14,C16,C18,C18-1 & C18-2 "sangat berguna untuk
kesihatan. C12 ialah " lauric oils " yang merupakan 45% hingga
55% jumlah kandungan di dalam " fatty acid" ( lihat kenyataan
kajian pakar tentang kelebihan lauric oil ).
Jadual %
pecahan fatty Acid yang bias terdapat dalam Minyak Kelapa Dara.
|
Fatty acid
|
%
w/w |
|
C6 |
1.34 |
|
C8 |
9.87 |
|
C10 |
6.87 |
|
C12 ( Lauric Oil )
|
49.92 |
|
C14 |
17.96 |
|
C16 |
6.97 |
|
C18 |
2.39 |
|
C18-1 |
4.14 |
|
C18-2 |
0.57 |
|
Total:
|
100% |

|
|
|

-
Saiz=150 ml
-
Kod=VCOP
-
M.K.Dara Pure
-
H. B. Ahli :Rm40.00
-
H. Ahli :xx+ Komisyen
|

-
Saiz=150 ml
-
Kod=VCOH
-
M.K.Dara +madu
-
Kegunaan:Diminum
-
H. B. Ahli=Rm40.00
-
H. Ahli=xx+ Komisyen
|
 |
|
|
Apakah standard
specifikasi item yang perlu di analisa untuk Minyak Kelapa
Dara ? |
|
Standard
item yang perlu di analisa untuk Minyak Kelapa Dara yang
digariskan oleh Pertubuhan pengeluar buah kelapa " Asian Pacific
Coconut Comitte ( APCC ) adalah seperti berikut:-
|
Standard Items for analysis
|
Value
( Contoh ) |
|
1-Saponification value (mg Koh/ g Oil ) |
278.07 |
|
2-Colour ( lavibond scale ) |
0.01 +
01Y |
|
3-Free Fatty acid (%) |
0.06 |
|
4-Iodine Value |
6.97 |
|
5-Solube protein (mg/ml) |
0.05 |
|
6-Vatamin E
(mg/100g) |
0.01 |
|
7-Peroxide value (Milliequivelents peroxide 0.2
oxygen/kg oil |
0.2 |
|
|
Bagamana minyak kelapa Dara
diproses? |
|
Minyak
Kelapa Dara BIO-ASLI dihasilkan secara organik melalui
proses pementasi semulajadi dengan tidak menggunakan haba
bagi memastikan struktur lemak / patty asid yang kaya dengan
"lauric Oil " tidak rosak seperti standard yang ditetapkan. |
|
Kelebihan Minyak Kelapa
Dara. |
-
1-Meyerupai lemak susu ibu.
-
2-Bagi ibu-ibu menyusukan anak,
yang mengambil minyak
kelapa dara sebagai sebahagian dari pemakanannya akan
mendapati paras lauric asid dan capric asid bertambah
secara ketara. (lihat keterangan terperinci dalam tajuk
Kesan Pengambilan Minyak Kelapa Dara Pada
Ibu-ibu Yang Menysukan Anak)
-
3-Anti Oksida ( Mencegah atau melambatkan cell mati )
4-Antivirus dan antibaktera.
Lauric
asid dalam minyak kelapa dara adalah 'medium chain fatty
asid' yang mempunyai tambahan fungsi yang amat berguna
untuk membentuk
monolaurin didalam tubuh manusia atau haiwan.
Monolaurin adalah bersifat antiviral, antibakteria dan
antiprotozoal. Monoglyceride yang digunakan oleh tubuh
manusia atau haiwan berperanan memusnahkan lapisan atau
kelongsong lipid pada virus, seperti HIV, herpes,
cytomegalovirus, influenza, berbagai bakteria pathogen
termasuk listeria monocytogenes dan heliobacter pylori,
serta protozoa seperti giardia lamblia. Setengah kajian
juga menunjukkan bahawa ia berfungsi sebagai
antimikrobial.
Tindakan
antiviral yang dikaitkan dengan monolaurin ialah ia
mampu mencairkan lapisan lipid dan phospholipid pada
kelongsong atau envelope virus yang menyebabkan
kerosakan pada envelope virus berkenaan. Secara
mudah, fatty asid dan monoglycerides menghasilkan kesan
pemusnahan ialah dengan menghancurkan dua lapisan
plasma membrane pada organism berkenaan.
Dari
beberapa kajian dan penyelidikan mutakhir ini, telah
membuktikan bahawa kesan antimikrobial monolaurin adalah
berhubung kait dengan gangguan terhadap sebarang isyarat
ke atas mekanisma cell organisma berkenaan untuk
replikasi (replication)
|
Jenis |
Deskripsi |
|
Virus |
Human immunodeficiency virus
HIV-1 or HIV+ |
|
Virus |
Herpes simplex virus-1 (HSV-1) |
|
Virus |
Herpes simplex virus-2 (HSV-2) |
|
Virus |
Herpes viridae (all) |
|
Virus |
Human lymphotropic viruses
(type 1) |
|
Virus |
Vesicular stomatitis virus (VSV) |
|
Virus |
Visna virus |
|
Virus |
Cytomegaloviru |
|
Virus |
Epstein-Barr virus |
|
Virus |
Influenza virus |
|
Virus |
Leukemia virus |
|
Virus |
Pneumonovirus |
|
Virus |
Sarcoma virus |
|
Virus |
Syncytial virus |
|
Virus |
Rubeola virus |
-
Jadual
jenis-jenis Lipid Coated Bacteria
|
Jenis |
Dekripsi |
|
Bacterium |
Listeria
monocytogenes |
|
Bacterium |
Helicobacter pylori
(gram negative) |
|
Bacterium |
Hemophilus influenzae
(gram negative) |

5-Meningkatkan Metabolisma tubuh manusia
6- Dikelaskan sebagai
functional food.
Sebagai
functional food, (functional food telah
didefinasikan pada An ILSI NORTH AMERICA SPECIAL CONFERENCE)
bererti ia adalah makanan yang
membekalkan komponen untuk kesihatan mengatasi komponen untuk
tenaga. Adalah dianggarkan sekitar 50 peratus kandungan fatty
asid didalam minyak kelapa dara adalah terdiri dari lauric asid,
dan 6 hingga 7 peratus kandungannya lagi adalah terdiri dari
capric asid.
Lauric asid adalah
'medium chain fatty asid' yang mempunyai tambahan fungsi yang
amat berguna untuk membentuk
monolaurin didalam tubuh manusia atau haiwan.
Monolaurin adalah bersifat antiviral, antibakteria dan
antiprotozoal monoglyceride yang digunakan oleh tubuh manusia
atau haiwan untuk memusnahkan lapisan atau kelongsong lipid pada
virus, seperti HIV, herpes, cytomegalovirus, influenza, berbagai
bakteria pathogen termasuk listeria monocytogenes dan
heliobacter pylori, serta protozoa seperti giardia lamblia.
Setengah kajian juga menunjukkan bahawa ia berfungsi sebagai
antimikrobial.
Sementara capric
asid adalah juga jenis 'medium chain fatty asid' yang juga
mempunyai kelebihan fungsi yang samabila ia membentuk sebagai
monocaprin di dalam tubuh manusia atau haiwan.
Monocaprin juga telah menunjukkan kesan keupayaan sebagai
antiviral terhadap HIV dan ia masih lagi dalam proses uji kaji
terhadap kesannya keatas herpes simplex dan keberkesanan
antibakterianya terhadap chlamydia. (Reuters, London June
29,1999).
Dr. Halldor
Thormar, ahli sains Icelandic, telah membuktikan bahawa
monolaurin yang berasal dari minyak kelapa dara , dapad membunuh
virus jenis 'lipid coated DNA dan RNA, termasuk HIV dan virus
herpes dan juga mikroorganism lain termasuk bakteria jenis gram
positive. Ketika ini Dr. Halldor Thormar dan pasukannya
merancang untuk meneruskan ujian fungsi serta kesan monocaprin
terhadap chlamydia dan virus herpes simplex.
|
|
Kesan
Pengambilan Minyak Kelapa Dara Pada Ibu-ibu
Yang Menyusukan
Anak. |
|
Lemak susu ibu
mengandungi asid lemak (fatty asid) yang unik. Ia terdiri
daripada 45 hingga 50 peratus 'saturated', sekitar 35 peratus
'monounsaturated', dan sekitar 15 hingga 20 peratus
'polyunsaturated'. Dari keseluruhan 'saturated fatty asid' yang
dihasilkan dalam mammary gland, 18 peratus darinya adalah
antimikrobial fatty asids, lauric asid dan capric asid.
Antimikrobial fatty asids ini memberikan bayi yang disusukan
perlindungan dari berbagai virus seperti HIV dan herpes,
bakteria seperti chlamydia dan helicobater, protozoa seperti
giardia lamblia.
Apabila ibu-ibu
yang menyusukan anak mengambil makanan dari lemak kelapa (terutama
minyak kelapa dara, kelapa parut dan santan kelapa) paras
kandungan lauric asid dan capric asid akan bertambah secara
ketara didalam susu. (lihat The American Journal of Clincal
Nutrition, diterbitkan pada tahun 1998). Ini bererti kandungan
jumlah perlindungan antimikrobial lauric asid dan capric asid
dalam susu ibu berkenaan akan bertambah, yang akhirnya
memberikan lebihan perlindungan kepada bayi yang disusukan.
Menurut beberapa
kajian, tanpa tambahan lauric asid dari pemakanan, susu ibu
masih mengandungi sekitar 3 peratus lauric asid dan 1 peratus
capric asid yang dihasilkan oleh mammary gland ibu berkenaan,
dan tahap kandungan lauric asid dan capric asid yang dihasilkan
berbeza diantara setiap ibu yang menyusukan anak. Walau
bagaimanapun apabila lauric asid diambil melalui pemakanan
seperti lemak kelapa dalam kelapa parut, kandungan lauric asid
di dalam susu ibu bertambah secara ketara sehingga tiga
kali ganda berbanding kandungan asal, sementara kandungan
capric asid bertambah hampir dua kali ganda. Keadaan ini dapat
memberikan bayi yang disusukan perlindungan yang lebih dari
berbagai virus virus, bakteria dan protozoa.
(Francois CA,
Connor SL, Wander Rc, Connor WE. Acute effects of dietary fatty
acids on the fatty acids of human milk. American Journal of
Clinical Nutrition 1998;67:301-308)
|
|
Others
benefits of this magic Oils ( VCOP & VCOH ) |
Research and
clinical observation have shown that medium-chain fatty
acids (MCFA's) like those found in coconut Oil, may provide
a wide range of health benefits. Some of these are
summarized below :
-
Reduce viruses
load that cause influenza, hepatitis C measles and others
illnesses.
-
Kills bacteria
that causes pneumonia, earache, throat infections, dental
cavities, food poisoning, urinary tract infections,
meningitis, gonorrheal and dozens of
others diseases.
-
Expels or
kills tapeworms, lice, giardia and others parasites.
|
|
IMMEDIATE
RELEASE |
|
Pact Signed to Test Coco
Oil for AIDS Treatment |
Feb.
18, 1999,
Manila
- The official agreement covering the first
clinical tests using coconut oil and its fatty acid,
monolaurin, to treat HIV/AIDS patients has been signed.
The memorandum of understanding among the three agencies
doing the clinical tests - the Philippine Coconut Research
and Development Foundation (PCRDF), United Laboratories and
the San Lazaro Hospital - was signed yesterday, making
possible the first medical research in the Philippines
against AIDS.
PCRDF
Chairman Maria Clara Lobregat told reporters
that government will not spend a single centavo
with this trial, and it will determine the
efficacy of coconut chemicals. Health
Secretary Alberto Romualdez said the trial needs
approval and protocol, and institutional ethics
review board will assess issues on using human
subjects for research purposes. He welcomed the
fact that the government will not shoulder the
expenses for the tests. "It is very
expensive, but since the DOH does not have that
kind of money and the private sector does, then
we can ask patients to participate," he said.
The tests
involve 15 Filipino patients: 12 females and
three males in the early stages of HIV
infection. Tayag said the trial seeks to achieve
what experts in the United States have found out
in research - - that coconut chemicals increase
the CD4 cell count and lower the viral load of
HIV patients to undetectable levels. Dr.
Eric Tayag, chief epidemiologist of the
hospital, said the CD4 cells are the body's
first line of defense against infection and
disease, but they are also the first to be
attacked by the HIV. The viral load is the
amount of the virus in the blood. It will
cost the 15 patients P300,000 each in coconut
oil and monolaurin capsules, but he said this
will not cost the hospital anything.
Dr. Conrado
Dayrit, president of the National Academy of
Science and Technology and a member of the PCRDF
board, explained that HIV, the virus that causes
AIDS, has a fatty envelop, and monolaurin can
penetrate and dismember this envelop rapidly
when ingested.
Monolaurin
is a substance derived from
lauric acid,
a component of the coconut. It is the most
important and most effective component of
coconut oil. "It disrupts the membrane
coating the envelop by softening it first. If
this happens, the virus will die," he said.
The PCRDF is
funding the trial, but United Laboratories will
receive the technology of processing the
monolaurin
capsules.
(Philippine
Headline News Online)
 |
|
NEJM: AZT may harm
fetus unnecessarily in HIV-positive pregnant women |
|
December 1,
1999, lauric.org - Ioannidis and Contopoulos-Ioannidis
note in their Nov. 25 1999 NEJM letter to the editor that
the study by Mofenson et al (August 5, 1999 NEJM) on
perinatal transmission of
HIV
in women treated with zidovudine (AZT), did
not support the concluding statement by Mofenson et al that
antiretroviral therapy "should be recommended to all
infected pregnant women regardless of their HIV-1 RNA
levels". The authors also report that they have extended the
results of Garcia et al (NEJM Aug 5 1999) on the predictive
value of viral load to 10 studies and noted that in women
with low viral loads (below 1000 copies per milliliter)
there are no lower rates of transmission with treatment with
AZT as opposed to no treatment. Although both Mofenson et al
and Garcia et al agree that comments by Ioannidis and
Contopoulos-Ioannidis are correct, they nevertheless support
the use of AZT to reduce the risk of transmission of
HIV-1 or other treatment regimens for those women who do
not wish to expose the fetus to antiretroviral drugs during
pregnancy. For women who elect the latter course, Lauric.org
continues to suggest the safe and effective adjunct dietary
supplementation with
sources of
lauric acid and
capric acid, which are known for their effectiveness in
significantly lowering
viral loads. |
|
Comments on JAMA Report: Reducing Viral Loads in
Breastfeeding Mothers Lowers Transmission Rate |
|
August 27,
1999, lauric.org - Miotti and colleagues,
JAMA August 25, 1999 report the results of a study
measuring "HIV
Transmission Through
Breastfeeding." They conclude that the risk of
transmission is greatest in the early months of
breastfeeding. The cumulative rates were 3.5%, 7.0%,
8.9%, and 10.3% at the end of months 5, 11, 17, and 23
respectively. The incidence per month was reported as 0.7%
during the period from age 1 to 5 months, 0.6% during the
period from age 6 to 11 months, and 0.3% during age 12 to 17
months. The significance for the trend was P=.01.
Lauric.org notes that the inclusion of a source of
lauric acid to the diets of the breastfeeding
HIV
positive mothers would help to lower the
level of virus in their milk and thus could help to lower
the rate of transmission in populations such as these
mothers in Malawi where
breastfeeding is important for survival of the infant.
Adding a functional food such as
coconut to the mother’s diet would be beneficial because
it would provide increased
lauric and capric acid in
mother's mi |
|
Lauric.org:
Mother-Infant HIV Transmission Could Be Reduced
through Viral Lowering with Lauric and Capric Acid |
|
August 6, 1999,
lauric.org - Garcia et al, (New
England Journal of Medicine August 5,
1999;341:394-402) have reported that the
maternal plasma
HIV-1 RNA levels (viral load) are predictive
of the risk of perinatal transmission, although
not of the timing of that transmission. This
report is from The Women and Infants
Transmission Study, an ongoing multicenter,
prospective study of the perinatal transmission
of
HIV-1 and the natural history of
HIV-1 infection in pregnant women and their
infants.
The study included
women who were treated with zidovudine and those
who were not. With an increasing geometric mean
of the levels of plasma HIV-1 RNA levels (viral
load) there was an increasing rate of
transmission from mother to infant up to levels
exceeding 100,000 copies of virus per milliliter
(mL). When the maternal level was less that 1000
copies of virus per mL (0 of 57 women), the rate
was zero percent; when the level was between
1000 and 10,000 copies per mL (32 of 193 women),
the rate was 16.6 percent; when the level was
between 10,001 and 50,000 copies per mL (39 of
183 women), the rate was 21.3 percent; when the
level was 50,001 to 100,000 copies per mL (17 of
54 women), the rate was 30.9 percent; and when
the level was greater than 100,000 copies per mL
(26 of 64 women), the rate was 40.6 percent.
The highest rate
was 63.3 percent for women who had levels of
virus greater than 100,000 and who had not
received zidovudine. However, for women whose
levels were between 50,000 and 100,000, the rate
of vertical transmission was the same whether
they received zidovudine (31.2 percent) or did
not received zidovudine (31.6 percent).
Lauric.org believes that this research
reinforces the comments from an
earlier response
by lauric.org. Monolaurin, the
monoglyceride of lauric acid, destroys the
HIV-1 virus. If
HIV-1-infected pregnant women were given a
source of lauric acid during pregnancy,
there could be additional lowering of viral
load, which could be helpful in preventing
vertical transmission of the virus.
Further, those
infants who acquire
HIV-1 infection by vertical transmission
from their
HIV-1-infected mothers are candidates for
the
adjunct antiviral nutritional support
from
lauric fats in their infant formula. Since
the current medical recommendations prevent
these infants from receiving
human milk from their
HIV-1-infected mothers, they need to be
given infant formulas. There was a time when
most of the infant formulas in the United States
could be counted on to have a source of
lauric acid and capric acid in their
formulation to match that found in human milk.
This is no longer true for many of the infant
formulas. Additionally, older
HIV-1-infected children, who consume regular
diets, could benefit from a source of
lauric acid such as
desiccated
coconut
or coconut milk
products.
 |
|
Lauric.org Notes
Dual Importance Regarding CMV and HIV |
|
July 7, 1999,
lauric.org
- Kovacs, et al (N
Engl J Med. July 8, 1999;341:77-84) have reported from a
prospective study that infants born to HIV-1-infected
mothers who are found to also be HIV-1-infected are at
greater risk for the development of
cytomegalovirus (CMV)
and for
HIV-1 disease progression than are those infants born to
HIV-1-infected mothers but who are not themselves
HIV-1-infected.
The researchers
concluded that "HIV-1-infected infants who
acquire
CMV
infection in the first 18 months of life
have a significantly higher rate of disease
progression and central nervous system disease
than those infected with HIV-1 alone." Further,
among those infants who are HIV-1-infected, the
infants who develop
CMV
continue to have a higher rate of
CMV
and more severe disease at four years of
age.
Infants who are
HIV-1-infected have a higher rate of
CMV
infection at 6 months than those who are not
HIV-1-infected (39.9 vs 15.3 percent). At age 18
months, those infants who are HIV-1-infected and
who also have
CMV
infection have higher rates of HIV-1 disease
progression (70.0 percent) than those who are
only HIV-1-infected (30.4 percent). In those
children who were only HIV-1-infected, rapid
progression of HIV-1 disease was related to
their having higher levels of virus (i.e.,
higher viral load).
Monolaurin, the monoglyceride of lauric
acid, destroys
CMV, as well as other herpes viruses and
HIV-1. If HIV-1-infected pregnant women were
given a source of lauric acid during pregnancy,
there could be additional lowering of viral
load, which could be helpful in preventing
vertical transmission of the virus.
Further, those
infants who acquire HIV-1 infection by vertical
transmission from their HIV-1-infected mothers
are candidates for the adjunct antiviral
nutritional support from lauric fats in their
infant formula. Since the current medical
recommendations prevent these infants from
receiving human milk from their HIV-1-infected
mothers, they need to be given infant formulas.
There was a time when most of the infant
formulas in the United States could be counted
on to have a source of
lauric acid and
capric acid in their formulation to match
that found in
human milk. This is no longer true for many
of the infant formulas.
The older
HIV-1-infected children, who consume regular
foods, could benefit from a source of lauric
acid such as
desiccated
coconut
products.
|
|
Lauric.org
Comments on Icelandic HIV Research |
|
July 1,
1999, lauric.org - Dr. Halldor Thormar, the
Icelandic scientist, who previously showed that monolaurin,
which comes from the fat in coconut, kills lipid coated DNA
and RNA viruses including HIV and herpes viruses as well as
other microorganisms including gram positive bacteria has
just announced the potential effectiveness of monocaprin
dissolved in a gel in killing HIV. Monocaprin also comes
from the fat in
coconut in the form of capric acid (C:10). Thormar and
his colleagues plan to continue the tests with monocaprin
against chlamydia and herpes simplex virus. |
|
Lauric.org
Responds to FDA Ban on DHA |
June 1, 1999, lauric.org
- Several fatty
acids are very important for health and development. Among
them are lauric acid and docosahexaenoic acid (DHA). These
two fatty acids are found in human milk from lactating
mothers. Lauric acid is the medium-chain fatty acids used by
the infant to make antimicrobial monoglycerides to keep the
infant from getting infections. DHA is a long-chain omega-3
fatty acid that is absolutely essential for proper brain
development in the infant, and for healthy vision. Children
and adults also need a source of both lauric acid and DHA.
Lauric acid can only be obtained through foods and the best
source in the United States is coconut including
sulfite-free desiccated coconut. Children and adults can
make their own DHA if they have adequate dietary consumption
of the precursor to DHA, which is alpha-linolenic acid, and
if they also don’t have too much omega-6 vegetable oils or
partially hydrogenated vegetable oils (trans fatty acids) in
their regular diets. The best source of preformed DHA is cod
liver oil and fatty fish such as salmon, sardines, and
mackerel. (Copyright 1999 lauric.org) |
|
|
|